I. Introduction
Hydrogen-based magnet ic resonance ( MR) imaging provides st ructural , runctional, and fl ow information non-invasivcly. The techn ique is based on the interact ion or the magnetic moment • Tel.: + 12166875396; fax: + 12166879220.
E·mail ilddress: g.chulzim;!vroudiS@CSuohio.edu of hydrogen nuclei (protons) with applied mag netic fields. If a mass of protons is placed inside a static magnetic field , the magnetic moments of the protons lend to align pa rallel and anti-parallel with the direction of the stat ic fie ld. The protons inside the magnetic field are in a complex rota tional motion, called precession , with a frequency that depends on the st rength or the magnetic field . Using radio-rrequeney pulses with a rrequeney equal to this precession frequency, the protons can be energetically excited. While they return to equi librium, they emit a signal that is used to recon struct an image. By applying a combination of magnetic field gradients in the x-, y-, and z-direc tion (by convention the frequency encoding direc tion, the phase encoding direction, and the slice selection direction, respectively (Fig. 1) ), the posi tion of the excited protons can be spatially en coded. The raw data is in the frequency domain (k-space). Every time the protons are excited and then return to equilibrium, the received signal fills one or more lines of k-space. After the k-space is filled, an inverse two-dimensional Fourier trans form reconstructs the image in the space domain.
An important feature of MR is its ability to measure flow velocity in any spatial direction using a technique called MR phase velocity mapping (PVM). By applying the proper bipolar magnetic field gradients (Fig. 1) , the velocity of the protons can be encoded in the phase of the received signal [1] . This phase-velocity encoding follows a linear equation: . The magnitude of the acquired signal is used to reconstruct the magnitude (structural) image, whereas the phase of the signal can be used to reconstruct the phase (velocity) map.
The ability of MR to characterize and quantify flow has found wide application in the clinical field for blood flow measurements in the aorta, pul monary artery, venae cavae, ventricles, and vari ous arteries and veins [2] [3] [4] [5] [6] [7] [8] [9] . MR has also been of value in non-biomedical applications, such as to characterize the velocity profiles of pure fluids and suspensions [10] , to study flow in porous med ia [11] , to visualize flow in fixed-bed reactors [12] , and as a rheological technique [13] and viscometer [14] . Studies have shown that conventional unseg mented k-space MR PVM is accurate and precise, with errors of less than 10% under both steady and pulsatile flow conditions [15] [16] [17] [18] [19] [20] . Clinical studies evaluating the technique for blood flow character ization or quantification found good correlations with Doppler ultrasound and flowmetric tech niques [6, 16, 21] . This review will focus on the application of MR PVM to two clinical problems: the quantitative diagnosis of heart valve regurgitation and the eval uation of the energetic performance of the total cavo-pulmonary connection. Recent studies on the potential of MR PVM for rapid velocity acqui sitions will also be discussed.
Heart valve regurgitation
The human heart has four one-way valves that regulate blood circulation. Two of these valves, the aortic and the mitral, are located in the left side of the heart (Fig. 2) . The aortic valve is located be tween the left ventricle and the aorta, and allows blood to flow during systole from the heart to all arteries that supply blood to organs and muscles. Under normal conditions, the aortic valve is com pletely closed during diastole. The mitral valve is located between the left atrium and the left ventri cle, and allows blood to fill the left ventricle during diastole. Under normal conditions, the mitral valve is completely closed in systole. However, be cause of a variety of reasons, these valves may not close completely allowing some blood to flow in the opposite direction. This disease is called valvu lar regurgitation and has a direct effect on cardiac function. In severe cases, it leads to death if it re mains untreated. Knowledge of the severity of regurgitation is diagnostically very important for proper patient management and for optimizing the time for valve replacement surgery. In the past, a number of clin ical approaches have been used to diagnose the severity of regurgitation. Unfortunately, these ap proaches usually lack reliability. Angiography [22] has been traditionally used to diagnose the disease, but it is invasive, only semi-quantitative, and in volves radiation exposure. A variety of echocar diographic and MR techniques [23] [24] [25] [26] [27] [28] [29] have also been evaluated to assess regurgitation focusing on the jet side of the regurgitant valve. Unfortu nately, these techniques are accompanied by tech nical limitations. One of the main problems is that they do not provide information about the main variable of interest, which is the volume of blood that regurgitates through the valve.
The regurgitant volume has been identified as an important index of the severity of regurgitation.
The first approach to determine the regurgitant volume was through volumetric MR imaging tech niques [21, 30] , from the difference between the left and right ventricular stroke volumes. Although the combination of left and right ventricular volumes with systolic and diastolic aortic and pulmonic flows can provide an estimate for the regurgitant volumes of the heart valves, this approach is not reliable in the presence of multi-valvular disease. Furthermore, the volumetric techniques estimate the regurgitant volume by combining measure ments at different sites in the heart and not focus ing on the site of interest, which is the regurgitant valve.
One of the first promising approaches to di rectly measure the mitral regurgitant volume was the proximal isovelocity surface area (PISA) meth od [31] . Although PISA can provide an estimate of the regurgitant volume, the reliability and accu racy of the method can be severely affected by geo metric uncertainties and by the complex nature of the flow field in the left ventricle due to the inter action of the regurgitant flow field with the aortic outflow field [32] .
Quantification of the aortic regurgitant volume with MR PVM
MR PVM can provide accurate flow quantifica tion in a tube from through-plane fluid velocity measurements. Since the ascending aorta is a tube, it is possible to quantify aortic blood flow by plac ing an imaging slice perpendicular to the long-axis of the aorta and measuring the through-plane velocity (Fig. 3) . The instantaneous aortic flow rate can be calculated by integrating this velocity over the aortic cross-sectional area. Then, an inte gration of this flow rate over diastole can finally provide the aortic regurgitant volume.
Initial in vivo investigations [33] on the clinical potential of this single slice MR PVM method showed the presence of high negative flow rates during diastole in the ascending aorta, indicating possible aortic regurgitation. Subsequent clinical studies [34] showed a fair correlation between the MR PVM regurgitant volume results and quali tative classification using aortography. With a 10 mm thick transverse slice placed in the ascend ing aorta at a level 1 cm below the innominate ar tery, the MR PVM results of the regurgitant volume showed good correlation with those using the ventricular volumetric MR method (r = 0.97) [21] . The reproducibility of the MR PVM data was also good (r > 0.97) [21] . The rather qualita tive evaluation of the single slice technique contin ued using thinner slices (5 mm) in the ascending aorta showing small interobserver and intraob server variations in measuring the regurgitant frac tion (the ratio of the aortic regurgitant volume to the left ventricular stroke volume). The MR PVM results showed good correlation with those from volumetric MR measurements and parallel trends with echocardiographic or aortographic grading of aortic regurgitation [35] . Similarly good correlations between MR PVM results and volu metric MR results (r = 0.97 for the stroke volume) were found when the imaging slice was moved to the aortic valve level [36] . These studies showed that MR PVM has high potential in quantifying the aortic regurgitant volume. However, because of the variety of slice location and imaging param eters, the effects of a number of functional, fluid mechanical, and technical factors on the reliability of the technique remained unknown. Factors such as the aortic compliance, the coronary artery flow and the flow environment in the vicinity of the regurgitant orifice could have serious effects on the accuracy of the regurgitant flow measure ments. These effects were studied both in vitro and in vivo.
In vitro [17] , measurements were performed with a slice perpendicular to the long axis of a compliant model of the aortic root (Fig. 4) , includ ing a regurgitant aortic valve and the coronary arteries. The most accurate measurements (closest agreement between the measured and true flow values) were taken when the slice was placed be tween the aortic valve annulus and the coronary ostia (r 2 = 0.995) (Fig. 5 ). When the slice was placed beyond the coronary ostia, coronary flow and aortic compliance (Fig. 6 ) negatively affected the accuracy of the measurements. The errors in the measurements (with respect to the known true flow values) were found to closely follow the magnitude of coronary flow and aortic com pliance.
Subsequently, the single slice technique was implemented in four healthy volunteers and 19 pa tients with aortic regurgitation, varying from mild to severe [8] . In 13 of the patients, the slice was placed at three locations: between the aortic valve flow waveform in the case of a patient with regur gitation. The measured regurgitant volume in all healthy subjects was zero. The MR PVM results correlated well with the angiographic and echocar diographic grading data. The repeatability of the MR PVM results was excellent and interobserver variability very small (r 2 = 0.987, p-value = 0.455). The measured regurgitant volume decreased as the distance of the slice from the aortic valve in creased, due to aortic compliance, in agreement to the previous in vitro results. Even for severe severity cases of regurgitation, the difference in the measured regurgitant volume between the clos est and the most distant location from the aortic valve was as high as 30%. Close to the valve, blood flow acceleration did not affect the accuracy of the velocity measurements. Because of the difficulty in determining the in vivo accuracy of the regurgitant volume measurements (due to the absence of any other technique to provide such data), the reliabil ity of the single slice technique was investigated by determining its precision [20] . In three healthy vol unteers and seven patients with aortic regurgita tion, single slice measurements in the ascending aorta were acquired twice. Comparison between the flow volume results from these two measure ments showed high levels of precision (r 2 = 0.993), confirmed statistically. The mean difference in the measured flow volumes between the two ser ies of measurements was <1 ml/beat. and the coronary ostia; at the sinotubular junc tion; and 2 cm above the sinotubular junction. In the remaining six patients, only one measurement was taken as close as technically possible to the aortic valve. The MR PVM measurements of the regurgitant volume were compared with angio graphic and echocardiographic grading of aortic regurgitation. Fig. 7 shows the measured aortic
The above results suggest that the most accu rate measurements of the regurgitant volume should be expected with a slice as close to the valve as technically possible. However, one of the prob lems of this strategy is the fact that the valve annu lus moves during the cardiac cycle. This motion may affect the reliability of proper slice placement and may introduce errors in the velocity measure ments. Nevertheless, newer corrective techniques have the potential to reduce or even eliminate these problems. One of these techniques involves an adaptation of slice position according to heart motion [37] . The basal cardiac plane is first marked and the slice position (offset and angula tion) is corrected based on the position of this basal plane throughout the cardiac cycle. The mea sured through-plane velocities are corrected to ac count for this basal motion. A preliminary clinical study implementing this corrective technique in 12 patients with aortic regurgitation [38] showed that the aortic annulus moved approximately 8 mm in the through-slice direction. The difference in the measured regurgitant fraction between implement ing and not implementing this corrective technique was approximately 60% for mild regurgitation, 15% for moderate regurgitation, and 7% for severe regurgitation.
The ability of MR PVM to quantify the flow rate in a vessel by measuring the through-slice velocity component has provided a unique method to quantify the aortic regurgitant volume. Knowl edge on proper slice positioning combined with the development of techniques to correct for cardiac motion are contributing to establishing this ap proach as the diagnostic method of choice.
Quantification of the mitral regurgitant volume with MR PVM
The quantification of the mitral regurgitant vol ume is more complicated than that of the aortic regurgitant volume. Although a single imaging slice placed in the ascending aorta is adequate to measure the regurgitant flow in aortic regurgita tion, the same is not true in mitral regurgitation, because of the interaction between the aortic out flow and the regurgitant flow in the vicinity of the mitral valve. In an indirect way, Fujita et al. [39] quantified the mitral regurgitant volume from the difference between the mitral diastolic inflow volume (measured with a single slice placed in the mitral valve) and the aortic systolic flow vol ume (also measured with a single slice in the aortic root). The regurgitant fraction correlated well with echocardiographic grading of mitral regurgitation (r = 0.87). The limitation of this approach is that it is not valid if the patient has both mitral and aortic regurgitation.
Since measuring the regurgitant flow with a sin gle slice is more complicated and less reliable in the case of mitral regurgitation compared to the case of aortic regurgitation, a more sophisticated meth od is required. As mentioned previously, MR PVM provides measurements of all three spatial components of the velocity vector in an imaging slice. Then, by acquiring a number of contiguous imaging slices with all three components of the velocity measured, a control volume in a form of an imaginary box surrounding the orifice can be considered (Fig. 8) . The velocity through the faces
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Control Volume Inflow Fig. 8 . The multi-slice control volume method. A number of contiguous imaging slices are positioned in the mitral valve region and all three spatial velocity components are measured. Then, because of the principle of mass conservation, the net inflow through the drawn boundaries of the control volume (shown here as a two-dimensional drawing; in reality it is a three-dimensional imaginary box) will be equal to the regurgi tant flow through the valve orifice.
of this control volume can be integrated over the total inflow area to calculate the flow rate. Based on the principle of mass conservation the net in flow into the control volume will be equal to the flow through the regurgitant orifice. The control volume method was initially evalu ated by Walker et al. [40] to quantify flow through an orifice in vitro. A very good agreement was found between the measured and the true flow rates (r = 0.99). Subsequently, a detailed in vitro study [18] was performed to investigate for the ef fects of control volume size, valve geometry, and aortic outflow on the accuracy of the method in the quantification of the regurgitant flow. The re sults showed that a properly sized control volume whose boundary voxels excluded the region of flow acceleration and velocity aliasing too close to the orifice provided accurate measurements of the regurgitant flow (Fig. 9) . A small control volume provided erroneous results, because the control volume boundaries were in the region of flow acceleration and velocity aliasing. A very large control volume generally provided inaccurate re sults due to reduced velocity sensitivity far from the orifice. Aortic outflow, orifice shape, and valve geometry did not affect the accuracy of the control volume measurements [18] . The effects of the mo tion of the mitral valve during the cardiac cycle on the accuracy of the control volume measure ments are significant [41] . Correction must be per formed to account for the velocity of motion of the valve leaflets. The problem of cardiac motion may be eliminated with corrective techniques, such as the one described in the case of aortic regurgita tion that involves an adaptation of slice position based on the motion of the basal cardiac plane [37] . This approach was implemented in a preli minary study in three patients with mitral regurgi tation [38] . The mitral regurgitant volume was determined from the difference between the mitral diastolic inflow volume and the aortic systolic flow volume. The mitral annulus moved approximately 12 mm in the through-slice direction. The differ ence in the regurgitant volume between imple menting and not implementing the corrective technique was approximately 19%.
By investigating the effects of additional physi ological factors (such as the motion of the leaflets, the presence of the chordae, etc.) and developing /implementing proper motion corrective proce dures, the control volume method has the poten tial to be clinically established as a diagnostic approach in mitral regurgitation. With the devel opment of ultra-fast MR PVM acquisition tech niques, the time to acquire all three components of the velocity of blood in a number of slices will be short enough to allow a complete examination within a reasonable amount of time.
Total cavo-pulmonary connection
Congenital heart disease is the most prevalent type of heart disease among children, commonly resulting in single-ventricle physiology. Surgical repair is essentially the only survival option. The initial procedure was the Fontan operation per formed in 1971 [42] , which involved a connection of the superior vena cave (SVC) to the distal end of the right pulmonary artery (RPA), and a con nection of the right atrial appendage to the proxi mal end of the RPA. Since 1971, the atrio pulmonary Fontan procedure has been modified to improve the flow energetics of the new circula tion. Currently, the most promising (and preferred) modification of the initial Fontan oper ation is the total cavo-pulmonary connection (TCPC) (Fig. 10 ), which involves a (multi-stage) surgical connection of the SVC and the inferior vena cava (IVC) directly to the RPA [43] . The pro cedure shows evidence of improved performance over the atrio-pulmonary connections.
The superiority of TCPC over the atrio-pul monary connection is partially due to the more streamlined flow patterns in TCPC, with less flow disturbances and, thus, lower fluid energy losses [43] [44] [45] [46] . Optimization of the TCPC has been inves tigated through several in vitro, numerical, and in vivo studies, focusing on the reduction of the en ergy losses of blood flow through the connection and providing proper blood flow distribution to the lungs. The optimal design should prevent strong flow collisions, allowing at the same time adequate IVC flow to both the RPA and the LPA, as shown by in vitro and numerical studies [47] [48] [49] . One way to avoid a direct caval flow col lision (and conserve energy) is to introduce an off set between the points of SVC and IVC connection with the RPA, as shown in vitro and in vivo [50] [51] [52] [53] . Addition of flaring at the connection site fur ther improves the energetics of the system reducing the energy losses as much as 68% due to smoother transition of SVC and IVC flows to the pulmonary arteries [48, [51] [52] [53] .
To evaluate the energetics of the TCPC, the mechanical energy losses can be calculated via a control volume analysis (according to which the ''energy loss'' is equal to ''mechanical energy IN'' minus ''mechanical energy OUT''). The practical limitation of this approach is that it requires inva sive pressure measurements (to determine the po tential part of the mechanical energy). This requirement makes the control volume approach less appealing clinically. A non-invasive technique to provide the energy loss in the TCPC is pref erable.
MR techniques including MR PVM have been used to study Fontan cases [52] [53] [54] [55] [56] [57] [58] offering signif icant information that may assist in post-operative patient monitoring. Clinical TCPC studies have provided quantitative information for the distribu tion of blood from the SVC and IVC to the LPA and RPA [54, 56] . The advantage of MR PVM being able to measure multi-directional blood velocity components [52, 53, 57, 58] has provided the ability to generate dynamic velocity vector maps in vitro [52] and in patients [53, 57, 58] , show ing (qualitatively) the fluid dynamic superiority (more unidirectional and less variable flow) of the TCPC over the atrio-pulmonary connection [57] and the importance of the presence of caval offset and flaring at the connection [53, 54] . The accuracy of the information in the MR velocity vector plots is high as shown in vitro by comparing the MR PVM vector plots ( Fig. 11 ) with those Fig. 11 . A velocity vector plot in a model of the total cavo pulmonary connection, constructed by combining two of the three measured spatial velocity components with MR PVM. from digital particle image velocimetry and with traditional particle flow visualization data [52] . There was agreement in the main features of the flow field (stagnation points, flow separation points, regions with secondary flows, etc.). A pre liminary in vivo study in twelve TCPC patients using three-directional MR PVM provided blood velocity vector plots with clear visualization of fluid mechanic features (streamlined flow, flow swirling) [53] . The in vivo findings were in general agreement with previously described in vitro re sults [51, 52] .
In addition to the qualitative flow field informa tion that MR PVM provides, the three-directional velocity data may be used to calculate the viscous dissipation, which, according to fluid mechanics theory, is equal to the mechanical energy loss in a flow field such as that in the TCPC [59] . The combination of the semi-qualitative information from the velocity vector-plots and the quantitative information on the energy loss can provide better monitoring of the success of a specific TCPC de sign post-operatively as well as guide cardiologists and cardiac surgeons to make proper treatment decisions.
Rapid magnetic resonance phase velocity mapping
Conventional unsegmented k-space MR PVM is performed using the gradient-echo sequence shown in Fig. 1 , with a bipolar velocity-encoding gradient in the desired direction for velocity mea surements. Because of the arterial flow pulsatility, multiple measurements are acquired during the cardiac cycle. The MR scanner can be triggered by the electrocardiogram (ECG) signal of the human subject to identify the beginning of the car diac cycle. Then, a number of acquisitions are per formed at different time points (time phases) throughout the cycle. Only one line of k-space for each time phase is acquired per heart beat. As a result, the acquisition of a single velocity measurement typically requires a few minutes (depending on heart rate and imaging parameters). Since blood flow quantification is usually only part of a complete cardiac MR examination and sincenew clinical protocols to diagnose valvular disease and the energetics of TCPC involve multiple veloc ity acquisitions [18, 41] , the unsegmented k-space technique becomes less practical clinically.
With the development of rapid imaging se quences, a segment of multiple k-space lines (in stead of a single line) can be acquired very rapidly per time phase. Consequently, the acquisi tion can be performed in seconds instead of min utes, with high temporal and spatial resolution [60] [61] [62] [63] [64] . If velocity-encoding gradients are added to the regular sequence, the flow velocity can be measured rapidly. Systematic in vitro [65, 66] and in vivo [67] studies have shown that segmented k-space MR PVM is very accurate in quantifying flow from through-plane velocity measurements, under a variety imaging parameters. The in vitro study involved flow quantification from throughplane velocity data in straight tubes, under a vari ety of steady and pulsatile flow conditions. The effect of the number of k-space lines per segment was studied by examining the unsegmented se quence and three segmented k-space schemes, with five [65] , seven [66] and nine [65] k-space lines per segment. Results showed that both segmented se quences provided very accurate flow quantifica tion (errors < 5%) under both steady and pulsatile flow conditions (p-value 0.05). Flow measurements in the human ascending aorta using the unsegmented sequence and the segmented se quence with seven and nine lines per segment [67] showed very close agreement (p-value 0.05) between the two segmented and the unsegmented technique. These results suggest that ultra-fast MR PVM has great potential for blood flow quantification clinically.
Conclusion
This review focused on magnetic resonance phase velocity mapping as a velocimetric and flowmetric technique. Specific clinical problems, such as the diagnosis of heart valve regurgitation and the evaluation of the energetic performance of the total cavo-pulmonary connection, for which MR PVM has great potential as a diagnostic and monitoring tool, were discussed. The potential for ultra-fast acquisitions was finally addressed.
As the clinical interest in more detailed quantita tive information about blood flow increases, the need for techniques such MR PVM becomes more apparent. This need combined with the continuous progress in MR technology promises even broader applications of MR PVM not only in the clinical but also in non-biomedical fields.
